Faces Of Digital Health

Too often, patients need to repeat their medical history when in contact with different healthcare providers. Consequently, clinicians need more time to make decisions than necessary because they can’t access patient data. London managed to digitize urgent care plans and make them available across 40 NHS Trusts and 1400 GP offices.  This episode presents the Urgent Care Plan Programme, aiming at giving clinicians easy access to patients’ desires about their care, as defined in their care plan. Patients can fill out an urgent care plan at various points in their patient journey. The problem so far has been that accessing these plans by different providers was often difficult. Now the situation is improved with an introduction of a regional platform that stores urgent care plans and enables different care teams to access them when needed.  Urgent Care Plan Programme is a part of OneLondon Portfolio. OneLondon is a project that supports a vision of joined-up health and care. It is a pan-London collaboration betw

Medical progress is driven by research, and good research requires good data. The largest single-site cancer center in Europe and the biggest chemotherapy center in the UK - The Christie NHS Foundation Trust runs 650 clinical trials at any given time. They recently went live with a new electronic Patient Reported Outcome Measures (ePROMs) service helping to connect patients with the hospital trust through their cancer journey. As explained by Phil Bottomley, EHR Strategic Lead at The Christie NHS Foundation Trust, the digitization of ePROMs is only the beginning of the digitalization process of over 600 clinical forms used in the hospital. The hospital’s digital transformation strategy is based on a data-first approach, ensuring that the used data models enable the creation of a longitudinal record. They chose openEHR specification - a product and vendor-independent specification, striving to make data independent of any software provider. Subscribe to the newsletter to receive a recap of the whole cancer se

We are in the middle of a series of discussions related to cancer care, treatment improvements, data management in oncology, and the promise of AI to find the right treatment for the right patient in the fastest possible manner. As mentioned by Xose M. Fernandez, a genomicist and former chief data officer at Institute Curie, a faster diagnosis could lead to less aggressive treatment and better patient outcomes.  We covered many perspectives so far: accessibility and cost of cancer treatments in the US and Canada in the first episode, genetics, data management, and the science of cancer; we talked about AI treatments and challenges in designing clinical trials in personalized medicine. This episode focuses on the consequences cancer diagnosis has after patients are cured. Many cancer survivors in long-term remission face restricted access to financial services because of their medical history. Some EU countries have already implemented the right to be forgotten - a right for patients not to disclose their medi

This is the 3rd episode in the Cancer Series. In this episode, you’ll hear a bit about precision medicine in oncology, drug repurposing and the increasing challenges precision medicine poses for clinical trials. I spoke with Tuvik Beker, CEO of Pangea Biomed, an Israeli-based company tackling oncology drug development and treatment recommendation by not only looking at the single mutations in tumor cells, which the Pharmaceutical industry has already found targeted therapies for. Cancer treatments are evolving very rapidly, but precision and targeted therapies are still only effective in roughly 10% of cancer patients. Pangea Biomed tries to understand broader gene activation patterns inside tumor cells and recommends a therapy that would help exploit cancer cells’ defense mechanisms.  As explained in simplified terms by Tuvik Beker. Cancer Series Ep. 1: Access to Care, Financial Toxicity and Healthcare IT in Oncology Speaker: David J. Stewart, MD, FRCPC, Professor of Medicine in the Division of Medical Onc

This is the second episode in a special series about cancer, cancer care, accessibility and technologies related to cancer care. The first episode focused on the current state of cancer care with a speaker from Canada - David J. Stewart, MD, FRCPC, Professor of Medicine in the Division of Medical Oncology at the University of Ottawa and The Ottawa Hospital. David explained the current state of cancer care, IT in oncology and financial toxicity of a cancer diagnosis for patients.  This, second episode, dives into genomics, the role of AI, and data science in oncology. Speaker: Xose M. Fernandez, genomicist and up until recently the Chief Data Officer at Institut Curie in France, one of the leading medical, biological, and biophysical research centers in the world.   SUBSCRIBE TO THE MONTHLY NEWSLETTER: https://fodh.substack.com/ www.facesofdigitalhealth.com Leave a rating or a review: lovethepodcast.com/facesofdigitalhealth Thank you! :)

There were an estimated 18.1 million cancer cases around the world in 2020, according to the World Cancer Research Fund International. According to the Comparator Report on Cancer in Europe 2020, the absolute number of people diagnosed with cancer rose around 50% in Europe over the past 20 years. However, the number of deaths only increased by 20%. The numbers show we’re making great strides in survival and treatments and early screenings. But because of the aging population, cancer care and prevention are rising global public health concerns.  In the next few episodes, we’ll talk about cancer, cancer care, and technology, the role of data and IT for improved care and research, AI in the search for new therapies, but also about cancer survivorship: what happens to patients after they are cancer free, but unfortunately far from back to the life they had before cancer.  Speaker in this episode is David J. Stewart, MD, FRCPC, Professor of Medicine in the Division of Medical Oncology at the University of Ottawa a

This episode explores the role of at-home diagnostic testing in managing and preventing sexually transmitted diseases. More than 1 million sexually transmitted infections (STIs), which include syphilis, gonorrhea, chlamydia, HIV hepatitis, and other infections, are acquired every day worldwide. The majority of STIs are asymptomatic early detection that much more important to prevent the spread of these diseases. According to WHO, globally, 38.4 million people were living with HIV at the end of 2021. Science has advanced immensively to help treat and manage HIV. For over a decade, populations at risk can take preventative pills, which prevent HIV infections by over 99%. Unfortunately, access to this prophylaxis shouldn’t be taken for granted. In the US, prevention is supposed to be covered by insurance under the Affordable Care Act. However, in September, a district court ruling in Texax potentially endangered this access. A Christian-owned company argued against the Affordable Care Act’s requirement that ins

This is the second episode where we will discuss healthcare delivery in Africa. In the previous episode, the entrepreneur and regulatory advisor Herve Mwamba from South Africa talked about stereotypes and medical device regulation in Africa (Full transcript: https://www.facesofdigitalhealth.com/blog/medical-device-regulation-mdr-africa). In this episode, you’re going to hear about an effort to manage non-communicable diseases in Africa better. Medtronic Labs is a nonprofit organization that works with governments and local communities in across Africa to create local ecosystems for the management of hypertension and diabetes. I spoke with Anne Stake, Chief Strategy and Product Officer at Medtronic Labs, who explained, how Medtronic Labs approached the African market, gaining of trust in the local communities and what challenges and innovations they observed on the ground in Kenya, Rwanda and Ghana. Did you read our newsletter yet? We finally have one! It only comes out monthly, filled with information abou

It’s September, it’s time for school and a new season of Faces of digital health podcast episodes. Faces of digital health strives to bring you an insight into digital health development across the world. We’re going to start this season in Africa. In this episode, South African entrepreneur, regulatory, and quality assurance consultant Herve Mwamba discusses the state of medical device regulation in South Africa and Africa more broadly, his observations about the consequences and problems related to the European Medical Device Regulation, his observation regarding innovation in Africa.  This is the first of a few episodes where speakers talked about the African market, so do make sure to subscribe to the show to be notified about other episodes automatically. In the next episode you’ll hear about chronic disease management in Kenya and Ghana, provided by Medtronic Labs, and after that, a discussion about the prevention of sexually transmitted diseases and how that can be improved with the rise of at-home te

There are “five rights” of medication use: the right patient, the right drug, the right time, the right dose, and the right route. It might seem obvious, but in practice, an error can occur at the level of each of these “right”s.  Unsafe medication practices and medication errors are leading cause of injury and avoidable harm in health care systems worldwide. According to WHO, the cost associated with medication errors has been estimated at $42 billion annually globally. The Australian Commission on Safety and Quality in Healthcare estimates that between 2% and 3% of all Australian hospital admissions are medication-related. In the UK, it is estimated that adverse drug reactions account for 10-20% of hospital in-patient admissions, according to the Chief Pharmaceutical Officer’s National Overprescribing Review, which was published in September 2021. This episode is a recording of a panel discussion at the Talking Healthtech Winter Summit in Australia in August. The panel session you’re about to hear is focuse

Patients dream about reliable and clinically meaningful digital innovations that would help improve their health in a smooth way. With the digital health market maturing, startups increasingly need to not only offer a good user experience but also comply with rigorous regulatory requirements and test their solutions in clinical trials. They need to go through long certification processes. For a few years now, Germany has in place a clear workflow for making digital health apps reimbursable. France is on its way to adopting a similar framework. In today’s episode, you will hear more about what companies need to do to get certified and reimbursed in Germany. I spoke with Jörg Trinkwalter, the Managing Director at ProCarement, a young startup that developed a telemedicine digital care solution for patients with heart failure. ProCarement is participating in the current cohort of the EIT Health Diginovation program. The Diginovation program links start-ups with an international consortium to accelerate the reimbu

In 2017, 57.7 million people were living with limb amputation due to traumatic causes worldwide. Apart from accidents, a person might need an amputation due to vascular diseases and diabetes. You might have come across increasingly sophisticated prosthetic limbs, which mimic human movements. The problem is, these are extremely expensive. Simple cosmetic prosthetic costs around $5,000, a functional prosthetic with a hook up to $10,000, and the latest myoelectric tech-enhanced ones cost up to $100,000. In this episode, Dima Gazda, CEO, and founder of Esper Bionics speaks about the development of the market, and how Esper Bionics operates, given that it has facilities in Ukraine. Subscribe to the newsletter: https://fodh.substack.com/ Website: www.facesofdigitalhealth.com  

This episode was first published in summer 2021, and is one of the most listened-to episodes from 2021. Taiwan spends only 6.4% of it’s GDP for healthcare, but has high satisfaction rates with healthcare, and is also very digitalized. In this episode, a closer look into healthcare in Taiwan is provided by Prof. Yu-Chuan Jack Li - a pioneer of artificial intelligence in medicine and translational biomedical informatics. Professor Li is Editor-in-Chief for BMJ Health & Care Informatics journal, the elected president of the International Medical Informatics Association (IMIA) and has devoted himself to evolving the next generation of Al in patient safety and prevention ("Earlier Medicine"). He has been deeply involved in biomedical informatics development in Taiwan and international cooperation on various continents, including Asia, America, Europe, and Africa. We spoke about the state of healthcare digitalization and AI in Taiwan. Subscribe to the newsletter: https://fodh.substack.com/ www.facesofdigitalhealt

One of the more prominent news in July was that according to Sifted, healthcare seed investments in Europe surpassed Fintech investments in June, making the health tech industry the industry that’s attracting the most investments. At the same time, in the US, Rock Health reported that digital health startups in the US raised 10.3 billion USD in the first half year of 2022, and StartupHealth reported a lower amount of investments compared to 2021. As StartupHealth noted, the 16B raised globally in Q1 and Q2, is still much more than in the first half of the year 2020. You can tune into a reflection on the current state of digital health globally by listening to the interview with the Startup Health president Unity Stoakes in April:  https://www.facesofdigitalhealth.com/blog/startup-health-unity-stoakes This episode takes a look at the European market and how aescuvest invests in digital health startups. We also talk about the rising problem of digital visual stress.  Speakers:  Simon Molitor, Associate Proje

This is a short documentary about medication-related patient safety. The documentary explores and offers an overview of the current challenges and technical solutions related to medication safety to raise awareness about the need to further improve medication-related patient safety. Unsafe medication practices and medication errors are a leading cause of injury and avoidable harm in health care systems across the world. Globally, the cost associated with medication errors has been estimated at $42 billion USD annually. Errors can occur at different stages of the medication use process. More than 237 million medication errors are made every year in England, the avoidable consequences of which cost the NHS upwards of £98 million and more than 1700 lives every year, indicate national estimates, published online in the journal BMJ Quality & Safety. The documentary premiered on 29 June 2021. Watch the documentary and full interviews with the speakers: https://www.facesofdigitalhealth.com/overdose-documentary Lear

Brazil had over 200 million people; how many of them sleep well? I hope you’re enjoying summer and resting enough. Many people have issues with sleeping: either not sleeping enough or sleeping poorly. Oftentimes, due to poor sleep hygiene, such as drinking coffee too late in the day, being exposed to blue light from phones, tablets, or computers right before getting to bed, etc. As listed by the Cleveland clinic, poor sleep results in a lack of alertness during the day, excessive daytime sleepiness, impaired memory, poor quality of life, and relationship stress. And more serious problems ​​associated with chronic sleep deprivation are high blood pressure, diabetes, heart attack, heart failure or stroke. Other potential problems include obesity, depression, reduced immune system function, and lower sex drive. The Brazilian startup Sleepup is trying to help people with sleep issues with an over-the-counter digital therapeutic. The DTx works on a behavioral change approach determined for each user. The first ste

How many times in the last year or two have you heard that patients should own their data or have control over their data? These statements sound simple but are much more complex once you start to look at the implications they might have in practice. In June,  the European Patients’ Forum Congress took place in Brussels. The topic was the digital transformation of healthcare, data sharing, and the role of patient organizations in this story.  This episode recaps some of the patient opinions at the EPF Congress. Watch the panel sessions: epfcongress.eu Read the recap: www.facesofdigitalhealth.com/blog/what-do-patients-really-think-about-data-recap-of-the-epf-congress

After several discussions about digital health in the APAC region, we are finishing the exploration in the region with a debate about healthcare digitalization in Pakistan. Pakistan has 242 million people. It’s the 5th largest population in the world. If you look at the website of the US state department, you will see advice to reconsider traveling to Pakistan. Life expectancy is low; the country attributes only 1.1 % of its GDP to healthcare. Yet, as mentioned by Zahid Ali, HIMSS Future50 Health IT Leader 2021, A digital health and innovation thought-leader and Consultant, the strategy Pakistan took in the fight against COVID was recognized by WHO as exemplary. So what is the state of healthcare digitalization in the country, and what can other countries learn from Pakistan? That’s the topic of today’s discussion. Do check out other episodes about the APAC region: https://www.facesofdigitalhealth.com/blog/digital-health-in-apac-an-overview-keren-priyadashini-microsoft-asia facesofdigitalhealth.com 

Dr. Keren Priyadashini is Regional Business Lead of Worldwide Health for Microsoft Asia. She leads the company’s healthcare business segment across 17 markets in Asia Pacific. Looking at digital health investments in the APAC region, according to Galen Growth Asia, last year China took the highest amount of funding (58.6%) for digital health, followed by India (22.3%), Australia (5.6%), Soth Korea (4.3%), and Singapore (3.8%). Healthcare expenditure differs a lot among countries: According to the World Bank, China attributed 5,3% of its GDP to healthcare, India 3%, Australia 9.91 %, Singapore 4%. How do these healthcare systems differ and does healthcare expenditure relate to investment in digitalization? More content at: www.facesofdigitalhealth.com Leave a rating or a review: www.lovethepodcast.com/facesofdigitalhealth.com

Many cancer survivors in long-term remission are faced with restricted access to financial services because of their medical history. Some EU countries have already implemented the right to be forgotten - a right for patients to not disclose their medical history. In most countries, the requirement is for the patient to be cancer-free for 10 years, France has changed this time limit to 5 years. Changes across Europe are happening very slowly. The understanding of the problem is poor and needs a lot more awareness. The incidence of cancer is increasing, however, at the same time, treatments are becoming more successful, returning long-lasting health to patients. Due to this scientific advancement, social care and policies should be changed as well.  Dr. Françoise Meunier is Member of the Belgian Royal Academy of Medicine, she was Director General of European Organisation for Research and Treatment of Cancer for 24 years from 1991 to 2015. She is also a Scientific Member of the European Cancer Patient Coalitio